Kate M. O’Dell

518 total citations
18 papers, 301 citations indexed

About

Kate M. O’Dell is a scholar working on Cardiology and Cardiovascular Medicine, Rheumatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kate M. O’Dell has authored 18 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 4 papers in Rheumatology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kate M. O’Dell's work include Atrial Fibrillation Management and Outcomes (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Medical Education and Admissions (2 papers). Kate M. O’Dell is often cited by papers focused on Atrial Fibrillation Management and Outcomes (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Medical Education and Admissions (2 papers). Kate M. O’Dell collaborates with scholars based in United States, Switzerland and United Kingdom. Kate M. O’Dell's co-authors include Sachin A. Shah, Eric G. Boyce, Deepti Vyas, Allen Shek, James S. Kalus, Dorothy S.P. Fan, Sanjay Kaul, Javed M. Nasir, Amanda Chan and Barbara Czerska and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, Journal of the American Heart Association and International Journal of Cardiology.

In The Last Decade

Kate M. O’Dell

18 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kate M. O’Dell United States 8 78 76 65 55 40 18 301
Heli Ghandehari United States 7 47 0.6× 75 1.0× 49 0.8× 70 1.3× 16 0.4× 12 421
Xiang Gu China 10 42 0.5× 104 1.4× 21 0.3× 34 0.6× 46 1.1× 24 336
Anna Glechner Austria 10 74 0.9× 19 0.3× 23 0.4× 22 0.4× 38 0.9× 23 402
Elio Gorga Italy 12 84 1.1× 158 2.1× 8 0.1× 18 0.3× 27 0.7× 23 396
Susan E. Fugate United States 9 94 1.2× 90 1.2× 23 0.4× 6 0.1× 13 0.3× 18 410
Yuji Miyoshi Japan 13 78 1.0× 49 0.6× 18 0.3× 17 0.3× 31 0.8× 37 447
Anish Desai India 7 164 2.1× 36 0.5× 32 0.5× 8 0.1× 12 0.3× 39 356
Sarmad Said United States 10 28 0.4× 66 0.9× 27 0.4× 22 0.4× 8 0.2× 20 315
Margaret Tiktin United States 6 16 0.2× 80 1.1× 27 0.4× 21 0.4× 24 0.6× 7 480
Mark Alan Fontana United States 11 26 0.3× 35 0.5× 28 0.4× 28 0.5× 24 0.6× 30 451

Countries citing papers authored by Kate M. O’Dell

Since Specialization
Citations

This map shows the geographic impact of Kate M. O’Dell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate M. O’Dell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate M. O’Dell more than expected).

Fields of papers citing papers by Kate M. O’Dell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate M. O’Dell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate M. O’Dell. The network helps show where Kate M. O’Dell may publish in the future.

Co-authorship network of co-authors of Kate M. O’Dell

This figure shows the co-authorship network connecting the top 25 collaborators of Kate M. O’Dell. A scholar is included among the top collaborators of Kate M. O’Dell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate M. O’Dell. Kate M. O’Dell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sevak, Rajkumar J., et al.. (2023). Impact of the COVID-19 Pandemic on US Pharmacy Academia Per Perspectives of Faculty and Administrators. American Journal of Pharmaceutical Education. 88(2). 100635–100635. 2 indexed citations
2.
Sevak, Rajkumar J., Anh B. Nguyen, Simran Randhawa, & Kate M. O’Dell. (2022). Variables affecting pharmacy students' pursuit and attainment of postgraduate residency and fellowship positions. Currents in Pharmacy Teaching and Learning. 14(10). 1298–1304. 2 indexed citations
3.
Patel, Sheel, et al.. (2021). Effects of the hangover secret on mitigating hangover symptoms: A pilot study. Health Science Reports. 4(3). e330–e330. 1 indexed citations
4.
Barber, Matthew D., Linda Brubaker, Ingrid Nygaard, et al.. (2019). Pain and activity after vaginal reconstructive surgery for pelvic organ prolapse and stress urinary incontinence. American Journal of Obstetrics and Gynecology. 221(3). 233.e1–233.e16. 18 indexed citations
5.
Shah, Sachin A., Allen Shek, Dorothy S.P. Fan, et al.. (2019). Impact of High Volume Energy Drink Consumption on Electrocardiographic and Blood Pressure Parameters: A Randomized Trial. Journal of the American Heart Association. 8(11). e011318–e011318. 62 indexed citations
6.
Boyce, Eric G., et al.. (2016). Impact of tofacitinib on patient outcomes in rheumatoid arthritis – review of clinical studies. Patient Related Outcome Measures. 7. 1–1. 20 indexed citations
7.
Shah, Sachin A., et al.. (2016). Electrocardiographic and blood pressure effects of energy drinks and Panax ginseng in healthy volunteers: A randomized clinical trial. International Journal of Cardiology. 218. 318–323. 32 indexed citations
8.
Amin, Alpesh, Allison Keshishian, Lin Xie, et al.. (2015). Comparison of major-bleeding risk and health care costs among treatment-naïve non-valvular atrial fibrillation patients initiating apixaban, dabigatran, rivaroxaban, or warfarin. MEF University Institutional Repository (MEF University). 2 indexed citations
9.
Vyas, Deepti, et al.. (2013). Tofacitinib. Annals of Pharmacotherapy. 47(11). 1524–1531. 53 indexed citations
10.
O’Dell, Kate M., PharmD, & Bcps. (2012). Tofacitinib: A novel oral Janus kinase inhibitor for rheumatoid arthritis. 4 indexed citations
11.
O’Dell, Kate M., et al.. (2012). New Oral Anticoagulants for Atrial Fibrillation: A Review of Clinical Trials. Clinical Therapeutics. 34(4). 894–901. 35 indexed citations
12.
O’Dell, Kate M., PharmD, & Bcps. (2012). Linaclotide: A guanylate cyclase type-C agonist for the treatment of constipation-predominant irritable bowel syndrome and chronic constipation. 2 indexed citations
13.
O’Dell, Kate M. & Sachin A. Shah. (2012). Evaluation of pharmacy practice residents' research abstracts and publication rate. Journal of the American Pharmacists Association. 52(4). 524–527. 43 indexed citations
14.
O’Dell, Kate M., et al.. (2010). Dronedarone for atrial fibrillation: An update of clinical evidence. 45(9). 275–283. 2 indexed citations
15.
Jennings, Douglas L., et al.. (2006). Predictors of rehospitalization after acute coronary syndromes. American Journal of Health-System Pharmacy. 63(4). 367–372. 5 indexed citations
16.
Jennings, Douglas L., James S. Kalus, & Kate M. O’Dell. (2005). Aldosterone Receptor Antagonism in Heart Failure. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(8). 1126–1133. 4 indexed citations
17.
O’Dell, Kate M., James S. Kalus, Suzan N. Kucukarslan, & Barbara Czerska. (2005). Nesiritide for secondary pulmonary hypertension in patients with end-stage heart failure. American Journal of Health-System Pharmacy. 62(6). 606–609. 13 indexed citations
18.
O’Dell, Kate M.. (2002). A Comprehensive Glove Choice. 3(6). 28–29. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heli Ghandehari Breakdown of academic impact, for papers by Xiang Gu Breakdown of academic impact, for papers by Anna Glechner Breakdown of academic impact, for papers by Elio Gorga Breakdown of academic impact, for papers by Susan E. Fugate Breakdown of academic impact, for papers by Yuji Miyoshi Breakdown of academic impact, for papers by Anish Desai Breakdown of academic impact, for papers by Sarmad Said Breakdown of academic impact, for papers by Margaret Tiktin Breakdown of academic impact, for papers by Mark Alan Fontana
Rankless by CCL
2026